MedTrace Logo

Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction

NCT02544594 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2019-10-14

No results posted yet for this study

Summary

This study compares standard treatment plus Extra-Corporal Life Support (ECLS) versus standard treatment alone in patients with cardiogenic shock due to myocardial infarction.

Conditions

  • Cardiogenic Shock

Interventions

DEVICE

Extra-Corporal Life Support (ECLS)

Extra-Corporal Life Support (ECLS) (from Sorin)

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Stefan Brunner, MD · Munich University Hospital

  • Steffen Massberg, MD · Munich University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-03-31
Completion
2019-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02544594 on ClinicalTrials.gov